Substance P (1-7)

Suppliers

Names

[ CAS No. ]:
68060-49-1

[ Name ]:
Substance P (1-7)

[Synonym ]:
2-[[5-amino-2-[[5-amino-2-[[1-[6-amino-2-[[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoic acid
PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-NH2: PKPQQFFGLM-NH2PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-NH2: PKPQQFFGLM-NH2
ARG-PRO-LYS-PRO-GLN-GLN-PHE
Substance P Fragment 1-7
Substance P (1-7)
Substance P: 1-7

Chemical & Physical Properties

[ Molecular Formula ]:
C41H65N13O10

[ Molecular Weight ]:
900.03600

[ Exact Mass ]:
899.49800

[ PSA ]:
394.44000

[ LogP ]:
1.91700

[ Storage condition ]:
-20°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3.0

Articles

Effects of L-glutamate, substance P and substance P(1-7) on cardiovascular regulation in the nucleus tractus solitarius.

Regul. Pept. 46 , 102, (1993)

Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord.

Peptides 27 , 753-759, (2006)

Endomorphin-1 (EM-1) and endomorphin-2 (EM-2) represent two opioid active tetrapeptides with high affinity and selectivity for the mu-opioid (MOP) receptor. Both EM-1 and EM-2 exhibit strong inhibitio...

Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.

Eur. J. Pharmacol. 626 , 250-255, (2010)

We have recently explored the role of the tachykinin substance P neuroactive fragment substance P(1-7) in the mediation of anti-inflammatory effects using a blister model in the rat paw (Wiktelius et ...


More Articles

Related Compounds

  • substance P (1-7)
  • Substance P (1-6)
  • Substance P (1-9)
  • substance P (1-4)
  • Substance P(1-4)
  • Substance P (7-11)
  • 1-{[(1-ethyl-1H-pyrazol-5-yl)methyl]amino}-2-methylpropan-2-ol
  • 1-ethyl-3,9-dimethyl-7-[(3-methylphenyl)methyl]-5a,9a,10,10a-tetrahydro-4H-purino[8,7-c][1,2,4]triazine-6,8-dione
  • 7-[(2-fluorophenyl)methyl]-3,9-dimethyl-1-propyl-5a,9a,10,10a-tetrahydro-4H-purino[8,7-c][1,2,4]triazine-6,8-dione
  • 1-Tert-butyl-3-((5-bromo-3-(chloromethyl)pyridin-2-yl)methyl)-1h-pyrrolo[2,3-b]pyridin-2(3h)-one
  • N-cyclopentyl-2,6-dimethyloxan-4-amine
  • 3,9-dimethyl-7-[(2-methylphenyl)methyl]-1-(2-methylprop-2-enyl)-5a,9a,10,10a-tetrahydro-4H-purino[8,7-c][1,2,4]triazine-6,8-dione
  • 7-[(2-chloro-6-fluorophenyl)methyl]-3,4,9-trimethyl-4,5a-dihydro-1H-purino[8,7-c][1,2,4]triazin-5-ium-6,8-dione
  • 5-Bromo-6-chloroindoline hydrochloride
  • 4-(3,4-Difluorophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid
  • 5-Fluoro-2-methyl-1,2,3,4-tetrahydroisoquinolin-3-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.